Medicine and Dentistry
CTLA-4
50%
Plasma
37%
Patient
25%
Neoplasm
25%
Biological Marker
25%
Reproducibility
25%
Immunoassay
25%
Membrane
12%
Malignant Neoplasm
12%
Tumor Cell
12%
Evaluation Study
12%
Enzyme Linked Immunosorbent Assay
12%
Awareness
12%
Cancer Immunotherapy
12%
Surgical Ablation
12%
Immunology and Microbiology
CTLA-4
50%
Immunity
37%
Blood Plasma
25%
Electric Potential
12%
Molecule
12%
Membrane
12%
Blood Level
12%
Tumor Cell
12%
Magnetism
12%
Immunoassay
12%
ELISA
12%
Cancer Immunotherapy
12%
Awareness
12%
Immune Status
12%
Magnetic Immunoassay
12%
Pharmacology, Toxicology and Pharmaceutical Science
Programmed Death-Ligand 1
100%
Cytotoxic T Lymphocyte Antigen 4
50%
Biological Marker
25%
Neoplasm
25%
Malignant Neoplasm
12%
Biochemistry, Genetics and Molecular Biology
CTLA-4
50%
PD-L1
50%
Electric Potential
12%
Blood Level
12%
Membrane
12%
Molecule
12%
Magnetism
12%
Cancer Immunotherapy
12%
Magnetic Immunoassay
12%
Awareness
12%
Immune Status
12%